Amlodipine Besilate + Atenolol: Brands, Price & Uses in Bangladesh

Amlodipine Besilate + Atenolol is a fixed-dose combination of a dihydropyridine calcium channel blocker (amlodipine) and a cardioselective beta-1 blocker (atenolol). It is indicated for:

• Hypertension (established use): Amlodipine Besilate + Atenolol is used in patients with essential hypertension whose blood pressure is not adequately controlled on amlodipine or atenolol monotherapy alone, or in patients already controlled on the individual components at the same doses present in the combination, as a substitution for convenience.
• Not intended as first-line/initial therapy: Amlodipine Besilate + Atenolol is not recommended for initiating treatment; the individual component doses should first be titrated separately, and this fixed combination used only once appropriate doses for both components have been established.

Amlodipine Besilate + Atenolol is not approved as a stand-alone treatment for angina, arrhythmia, or post-myocardial infarction care; those indications apply to the individual components (amlodipine, atenolol) used alone at physician-determined doses, not to this fixed-ratio combination.

Hypertension (Adults)

Administration

• Swallow the tablet whole with a glass of water; do not crush or chew unless the product is specifically formulated for that purpose.
• Take Amlodipine Besilate + Atenolol at the same time each day to maintain consistent blood pressure control.
• Do not stop Amlodipine Besilate + Atenolol abruptly (see Precautions and Warnings) — dose reduction, when needed, should be gradual and physician-supervised.

Renal impairment

Because the atenolol component is renally eliminated, Amlodipine Besilate + Atenolol is generally not suitable for patients with significant renal impairment (creatinine clearance below approximately 35 mL/min); such patients should instead have the individual components dosed and adjusted separately by their physician.

Hepatic impairment

The amlodipine component is hepatically metabolized; a lower starting dose of amlodipine is generally advised in hepatic impairment. Individual component titration, rather than the fixed combination, is preferred when initiating therapy in these patients.

Side effects of Amlodipine Besilate + Atenolol reflect both of its components. Reporting frequency varies by individual dose and patient.

Common

• Peripheral (ankle/leg) edema — a well-recognized amlodipine-related effect
• Fatigue, tiredness, or reduced exercise tolerance
• Bradycardia (slow heart rate) and cold extremities — beta-blocker related
• Dizziness, lightheadedness, or headache
• Flushing
• Gastrointestinal upset (nausea, abdominal discomfort)

Less common but clinically important

• Symptomatic hypotension
• Worsening of heart failure symptoms
• Bronchospasm, particularly in patients with reactive airway disease (see Precautions and Warnings)
• Mood changes, sleep disturbance, or vivid dreams (beta-blocker related)
• Erectile dysfunction

Patients should seek prompt medical attention for severe dizziness, fainting, very slow heart rate, difficulty breathing, or swelling suggestive of heart failure while taking Amlodipine Besilate + Atenolol.